Ramosetron Pre-treatment for PONV and QT Prolongation

• Status: Completed
• Trial end date: 2018-02-28
• Target enrollment: 0
• Participant gender: Female

Summary

Ramosetron is commonly used to prevent postoperative nausea and vomiting (PONV) in the Eastern Asia. The prolongation of QTc interval is a main side effect. In this study, the pre-treatment time of ramosetron to decrease PONV, and QTc prolongation is compared.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Konkuk University Medical Center
• Treatments: Ramosetron

Criteria

Inclusion Criteria:

• patients who underwent laparoscopic gynecologic surgery

Exclusion Criteria:

• preoperative bradyarrhythmia in ECG